Scinovex
articleTop 1% cited

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

The FASEB Journal · 2004 · Vol. 18(1) · pp. 39–51
Stewart H. LeckerR. Thomas JagoeAlexander D. GilbertMarcelo D. GomesVickie E. BaracosJames L. BaileyS. Russ PriceWilliam E. MitchAlfred L. Goldberg

Abstract

Skeletal muscle atrophy is a debilitating response to starvation and many systemic diseases including diabetes, cancer, and renal failure. We had proposed that a common set of transcriptional adaptations underlie the loss of muscle mass in these different states. To test this hypothesis, we used cDNA microarrays to compare the changes in content of specific mRNAs in muscles atrophying from different causes. We compared muscles from fasted mice, from rats with cancer cachexia, streptozotocin-induced diabetes mellitus, uremia induced by subtotal nephrectomy, and from pair-fed control rats. Although the content of >90% of mRNAs did not change, including those for the myofibrillar apparatus, we found a common set of genes (termed atrogins) that were induced or suppressed in muscles in these four catabolic states. Among the strongly induced genes were many involved in protein degradation, including polyubiquitins, Ub fusion proteins, the Ub ligases atrogin-1/MAFbx and MuRF-1, multiple but not all subunits of the 20S proteasome and its 19S regulator, and cathepsin L. Many genes required for ATP production and late steps in glycolysis were down-regulated, as were many transcripts for extracellular matrix proteins. Some genes not previously implicated in muscle atrophy were dramatically up-regulated (lipin, metallothionein, AMP deaminase, RNA helicase-related protein, TG interacting factor) and several growth-related mRNAs were down-regulated (P311, JUN, IGF-1-BP5). Thus, different types of muscle atrophy share a common transcriptional program that is activated in many systemic diseases.

Muscle Physiology and DisordersGenetic Neurodegenerative DiseasesNeurogenetic and Muscular Disorders ResearchMuscle atrophyBiologySkeletal muscleAtrophyProtein degradationGene expressionInternal medicineUbiquitinCell biologyEndocrinology

MeSH terms

Adenosine TriphosphateAnimalsGene Expression RegulationMetallothioneinMuscular AtrophyNitrogenProteinsRNA, MessengerTranscription FactorsTranscription, GeneticProtein BiosynthesisExtracellular Matrix ProteinsMuscle, SkeletalGene Expression ProfilingUbiquitin-Protein Ligases

Funding

  • National Institutes of Health
Citations
1,529
FWCI
29.06
field-weighted impact
References
91
Percentile
100%
vs. same field & year
Citations per year
Cited by
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
American Journal of Physiology-Endocrinology and Metabolism · 2014 · 1,043 citations
Protein Degradation by the Ubiquitin–Proteasome Pathway in Normal and Disease States
Journal of the American Society of Nephrology · 2006 · 1,246 citations
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
Pflügers Archiv - European Journal of Physiology · 2011 · 358 citations
Glucocorticoids, metabolism and metabolic diseases
Molecular and Cellular Endocrinology · 2007 · 521 citations
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Cell Metabolism · 2012 · 1,196 citations
Autophagy Is Required to Maintain Muscle Mass
Cell Metabolism · 2009 · 1,249 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.